Showing 1251-1260 of 8543 results for "".
Considering Going Direct Pay?
https://practicaldermatology.com/topics/practice-management/considering-going-direct-pay/23552/A dermatologist shares thoughts on what “direct care” really means.The State of Pediatric Dermatology
https://practicaldermatology.com/topics/practice-management/the-state-of-pediatric-dermatology/23060/The subspecialty needs to expand its workforce to continue to meet critical patient need.Best-in-Class At-Home Beauty Devices for Dermatologists
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/best-in-class-at-home-beauty-devices-for-dermatologists/20724/An experience-based assessment of a growing market segment.Transitioning From Academia to Private Practice
https://practicaldermatology.com/issues/august-2025/transitioning-from-academia-to-private-practice/36705/YoungMD Connect recently hosted an “Ask Me Anything” mentorship session with Tina Bhutani, MD, MAS, FAAD, during which she discussed her shift in career trajectory from academia to private practice and the insights she gained along the way.How To Influence Others, Dermatology Practice-Style
https://practicaldermatology.com/topics/practice-management/how-to-influence-others-dermatology-practice-style/23963/Influence means “to have an effect on the behavior of someone or something.”When Our Health Care System Injures the Physician’s Soul
https://practicaldermatology.com/topics/practice-management/when-our-health-care-system-injures-the-physicians-soul/23845/One dermatologist’s quest to protect physicians from moral injury.ASDS Updates
https://practicaldermatology.com/conferences/asds-2022-annual-meeting/asds-updates/23823/The American Society for Dermatologic Surgery shined in Colorado for the first live annual meeting post pandemic.Rosacea Update: A Closer Look at Zilxi
https://practicaldermatology.com/columns/clinical-focus-1/rosacea-update-a-closer-look-at-zilxi/23339/Inside the approval of Zilxi for moderate-to-severe facial papulopustular rosacea.A Closer Look at Skyrizi
https://practicaldermatology.com/columns/clinical-focus-1/a-closer-look-at-skyrizi/23016/The newest IL-23 blocker for psoriasis may prove to be a blockbuster, according to analysts.Kybella Off-Label?
https://practicaldermatology.com/topics/practice-management/kybellaoff-label/21057/Experts weigh in on whether and how Kybella® may be used off-label.